These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 26990915)

  • 1. Dose-response association between hepatitis B surface antigen levels and liver cancer risk in Chinese men and women.
    Yang Y; Gao J; Li HL; Zheng W; Yang G; Zhang W; Ma X; Tan YT; Rothman N; Gao YT; Chow WH; Shu XO; Xiang YB
    Int J Cancer; 2016 Jul; 139(2):355-62. PubMed ID: 26990915
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Individual and combined effects of hepatitis B surface antigen level and viral load on liver cancer risk.
    Yang Y; Gao J; Tan YT; Li HL; Wang J; Ma X; Zheng W; Shu XO; Xiang YB
    J Gastroenterol Hepatol; 2018 May; 33(5):1131-1137. PubMed ID: 29065440
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cigarette smoking, alcohol drinking, hepatitis B, and risk for hepatocellular carcinoma in Korea.
    Jee SH; Ohrr H; Sull JW; Samet JM
    J Natl Cancer Inst; 2004 Dec; 96(24):1851-6. PubMed ID: 15601641
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis B virus infection and hepatocellular carcinoma among parous Taiwanese women: nationwide cohort study.
    Fwu CW; Chien YC; Kirk GD; Nelson KE; You SL; Kuo HS; Feinleib M; Chen CJ
    J Natl Cancer Inst; 2009 Jul; 101(14):1019-27. PubMed ID: 19535774
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutual confounding and interactive effects between hepatitis C and hepatitis B viral infections in hepatocellular carcinogenesis: a population-based case-control study in Taiwan.
    Sun CA; Farzadegan H; You SL; Lu SN; Wu MH; Wolfe L; Hardy W; Huang GT; Yang PM; Lee H; Chen CJ
    Cancer Epidemiol Biomarkers Prev; 1996 Mar; 5(3):173-8. PubMed ID: 8833617
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatitis B e antigen and the risk of hepatocellular carcinoma.
    Yang HI; Lu SN; Liaw YF; You SL; Sun CA; Wang LY; Hsiao CK; Chen PJ; Chen DS; Chen CJ;
    N Engl J Med; 2002 Jul; 347(3):168-74. PubMed ID: 12124405
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction between tobacco smoking and hepatitis B virus infection on the risk of liver cancer in a Chinese population.
    Liu X; Baecker A; Wu M; Zhou JY; Yang J; Han RQ; Wang PH; Jin ZY; Liu AM; Gu X; Zhang XF; Wang XS; Su M; Hu X; Sun Z; Li G; Mu L; He N; Li L; Zhao JK; Zhang ZF
    Int J Cancer; 2018 Apr; 142(8):1560-1567. PubMed ID: 29193051
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prediagnostic level of serum retinol in relation to reduced risk of hepatocellular carcinoma.
    Yuan JM; Gao YT; Ong CN; Ross RK; Yu MC
    J Natl Cancer Inst; 2006 Apr; 98(7):482-90. PubMed ID: 16595784
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk stratification of hepatocellular carcinoma in hepatitis B virus e antigen-negative carriers by combining viral biomarkers.
    Tseng TC; Liu CJ; Chen CL; Yang HC; Su TH; Wang CC; Yang WT; Kuo SF; Liu CH; Chen PJ; Chen DS; Kao JH
    J Infect Dis; 2013 Aug; 208(4):584-93. PubMed ID: 23656977
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Interaction among the relative risk factors of primary liver cancer in a case-control study].
    Zhao N; Yu S; Sun WM
    Zhonghua Liu Xing Bing Xue Za Zhi; 1994 Apr; 15(2):90-3. PubMed ID: 7923340
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictive power of hepatitis B 1762T/1764A mutations in plasma for hepatocellular carcinoma risk in Qidong, China.
    Muñoz A; Chen JG; Egner PA; Marshall ML; Johnson JL; Schneider MF; Lu JH; Zhu YR; Wang JB; Chen TY; Kensler TW; Groopman JD
    Carcinogenesis; 2011 Jun; 32(6):860-5. PubMed ID: 21474708
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical features of HBsAg seroclearance in hepatitis B virus carriers in South Korea: A retrospective longitudinal study.
    Park YM; Lee SG
    World J Gastroenterol; 2016 Nov; 22(44):9836-9843. PubMed ID: 27956808
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of hepatitis B in the southeast of China: a population-based study with a large sample size.
    Luo Z; Xie Y; Deng M; Zhou X; Ruan B
    Eur J Gastroenterol Hepatol; 2011 Aug; 23(8):695-700. PubMed ID: 21617533
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatitis B virus, aflatoxins, and hepatocellular carcinoma in southern Guangxi, China.
    Yeh FS; Yu MC; Mo CC; Luo S; Tong MJ; Henderson BE
    Cancer Res; 1989 May; 49(9):2506-9. PubMed ID: 2539905
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rate of incidence of hepatocellular carcinoma in patients with compensated viral cirrhosis.
    Chiaramonte M; Stroffolini T; Vian A; Stazi MA; Floreani A; Lorenzoni U; Lobello S; Farinati F; Naccarato R
    Cancer; 1999 May; 85(10):2132-7. PubMed ID: 10326690
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of hepatitis B and C virus infections on the natural history of compensated cirrhosis: a cohort study of 297 patients.
    Fattovich G; Pantalena M; Zagni I; Realdi G; Schalm SW; Christensen E;
    Am J Gastroenterol; 2002 Nov; 97(11):2886-95. PubMed ID: 12425564
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coexistence of hepatitis B surface antigen and antibody to hepatitis B surface may increase the risk of hepatocellular carcinoma in chronic hepatitis B virus infection: a retrospective cohort study.
    Seo SI; Choi HS; Choi BY; Kim HS; Kim HY; Jang MK
    J Med Virol; 2014 Jan; 86(1):124-30. PubMed ID: 24127328
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Temporal patterns of aflatoxin-albumin adducts in hepatitis B surface antigen-positive and antigen-negative residents of Daxin, Qidong County, People's Republic of China.
    Wang JS; Qian GS; Zarba A; He X; Zhu YR; Zhang BC; Jacobson L; Gange SJ; Muñoz A; Kensler TW
    Cancer Epidemiol Biomarkers Prev; 1996 Apr; 5(4):253-61. PubMed ID: 8722216
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk factors analysis for hepatocellular carcinoma in patients with and without cirrhosis: a case-control study of 213 hepatocellular carcinoma patients from India.
    Kumar M; Kumar R; Hissar SS; Saraswat MK; Sharma BC; Sakhuja P; Sarin SK
    J Gastroenterol Hepatol; 2007 Jul; 22(7):1104-11. PubMed ID: 17559381
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blood folate levels and risk of liver damage and hepatocellular carcinoma in a prospective high-risk cohort.
    Welzel TM; Katki HA; Sakoda LC; Evans AA; London WT; Chen G; O'Broin S; Shen FM; Lin WY; McGlynn KA
    Cancer Epidemiol Biomarkers Prev; 2007 Jun; 16(6):1279-82. PubMed ID: 17548697
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.